Medroxyprogesterone Acetate
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Medroxyprogesterone Acetate |
| DrugBank ID | DB00603 |
| KG Predictions | 63 |
| DL Predictions (≥0.7) | 84 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 63 knowledge graph predictions and 84 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| uterine corpus cancer | KG |
| endometrial cancer | KG |
| endometriosis (disease) | KG |
| endometriosis of uterus | KG |
| postmenopausal atrophic vaginitis | KG |
| postmenopausal osteoporosis | KG |
| endometrial carcinoma (disease) | KG |
| osteoporosis | KG |
| endometrium neoplasm | KG |
| uterine corpus cancer | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB00603
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.